Original Research
Published on 26 Feb 2025
Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial
in Skin Cancer
- 2,254 views
- 1 citation